Foundation supporting new study looking at a new treatment for children with IBD

Great news!  With your help we are teaming up with other groups across Europe to take part in the VEDOKIDS study. New treatments for children with Crohn’s and Colitis don’t come along too often so it is great to be able to take part in supporting a study that will be doing this.

Vedolizumab is a new treatment used in adults with IBD from 2015 with promising results but good quality studies in children have not been done yet. We have teamed up with the European Crohn’s & Colitis Organization, the European Society of Pediatric Gastroenterology Hepatology and Nutrition plus Shaare Zedek Hospital in Jerusalem to carry out the study. The team will study how well children respond to the Vedolizumab treatment as well as measuring levels of the drug over the course of a year in 120 children from at least 16 different hospitals.

We hope this study will be able to identify children who will benefit from this treatment at an early stage and who otherwise have a limited choice of treatments for their IBD.

We will keep you up to date with the progress and thank all of our supporters for contributing to this incredible study.